Definitive Healthcare Q2 revenue slightly misses estimates despite customer gains

Definitive Healthcare

10/08/2026 21:22

Overview
Healthcare data analytics firm's Q2 revenue fell 9% yr/yr, slightly missing analyst expectations
Adjusted net income for Q2 declined from prior year
Company cites improved net dollar retention and new AI platform launch as key highlights

Outlook
Definitive Healthcare sees Q3 revenue between $54.0 mln and $55.0 mln
Company expects full-year 2026 revenue of $220.0 mln to $222.0 mln
Company expects Q3 adjusted net income per diluted share of $0.04 to $0.05

Result Drivers
NET DOLLAR RETENTION - Co said net dollar retention improved year-over-year for a second consecutive quarter
CUSTOMER WIN-BACKS - Co cited strong win-back momentum and new customer agreements across end markets
AI PLATFORM LAUNCH - Launch of new AI-powered healthcare intelligence platform highlighted as a milestone in innovation strategy

Company press release: ID:nGNX1FXXQN

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Slight Miss*
$55.20 mln
$55.48 mln (6 Analysts)
Q2 Net Loss
 
$7.45 mln
 
Q2 Gross Profit
 
$40.54 mln
 
*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 5 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the software peer group is "buy."
Wall Street's median 12-month price target for Definitive Healthcare Corp is $2.75, about 285.4% above its August 7 closing price of $0.71
The stock recently traded at 4 times the next 12-month earnings vs. a P/E of 5 three months ago

Reuters Recommended Reads
Aug 10 - Accendra Health Q2 profit, revenue miss estimates on large payor exit
Aug 9 - RadNet raises outlook as Q2 revenue jumps 25%, adjusted EPS beats estimates 
Aug 10 - Quanterix Q2 revenue rises 34% but cuts 2026 outlook

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)